Expedited Programs for Regenerative Medicine Therapies for Serious Conditions (FDA)

 

(Silver Spring, MD) The FDA provides a recent guidance document on the use of expedited development programs for regenerative medicine advanced therapies (RMAT).

 

PUBMED ARTICLES CLINICAL TRIALS